Dashboard
Manage Tickers

ICLR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

td-cowen-maintains-hold-on-icon-lowers-price-target-to-172
TD Cowen Maintains Hold on Icon, Lowers Pr...
10/24/2025 16:44:56

TD Cowen analyst Charles Rhyee maintains Icon (NASDAQ:ICLR) with a Hold and lowers the price target from $183 to $172.

6-analysts-assess-icon-what-you-need-to-know
6 Analysts Assess Icon: What You Need To Know
10/24/2025 14:00:57

barclays-maintains-equal-weight-on-icon-lowers-price-target-to-185
Barclays Maintains Equal-Weight on Icon, L...
10/24/2025 13:45:03

Barclays analyst Luke Sergott maintains Icon (NASDAQ:ICLR) with a Equal-Weight and lowers the price target from $190 to $185.

icon-narrows-fy2025-adj-eps-guidance-from-1300-1400-to-1300-1320-vs-1322-est-narrows-fy2025-sales-guidance-from-7850b-8150b-to-8050b-8100b-vs-7977b-est
Icon Narrows FY2025 Adj EPS Guidance from ...
10/22/2025 20:28:57

Icon (NASDAQ:ICLR) narrows FY2025 Adj EPS guidance from $13.00-$14.00 to $13.00-$13.20 vs $13.22 analyst estimate. Narrows FY20...

icon-q3-adj-eps-331-beats-329-estimate-sales-2043b-beat-1983b-estimate
Icon Q3 Adj. EPS $3.31 Beats $3.29 Estimat...
10/22/2025 20:26:49

Icon (NASDAQ:ICLR) reported quarterly earnings of $3.31 per share which beat the analyst consensus estimate of $3.29 by 0.76 pe...

Core News & Articles
Earnings Scheduled For October 22, 2025
10/22/2025 08:32:26

examining-the-future-icons-earnings-outlook
Examining the Future: Icon's Earnings Outlook
10/21/2025 16:04:51

what-analysts-are-saying-about-icon-stock
What Analysts Are Saying About Icon Stock
10/02/2025 20:01:43

barclays-maintains-equal-weight-on-icon-raises-price-target-to-190
Barclays Maintains Equal-Weight on Icon, R...
10/02/2025 13:49:52

Barclays analyst Luke Sergott maintains Icon (NASDAQ:ICLR) with a Equal-Weight and raises the price target from $180 to $190.

11-analysts-assess-icon-what-you-need-to-know
11 Analysts Assess Icon: What You Need To ...
09/09/2025 13:01:14

jefferies-downgrades-icon-to-hold-lowers-price-target-to-175
Jefferies Downgrades Icon to Hold, Lowers ...
09/09/2025 10:57:32

Jefferies analyst David Windley downgrades Icon (NASDAQ:ICLR) from Buy to Hold and lowers the price target from $220 to $175.

icon-plc-confirms-that-there-is-no-change-to-its-financial-guidance-for-fy--2025
ICON Plc Confirms That There Is No Change ...
09/04/2025 13:42:27

-SEC Filing

icon-ceo-dr-steve-cutler-to-retire-coo-barry-balfe-appointed-as-successor-effective-october-1-2025
ICON CEO Dr. Steve Cutler To Retire; COO B...
09/04/2025 12:12:46

ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the ...

rothschild--co-upgrades-icon-to-buy-raises-price-target-to-236
Rothschild & Co Upgrades Icon to Buy, Rais...
09/03/2025 15:12:50

Rothschild & Co analyst Jamie Clark upgrades Icon (NASDAQ:ICLR) from Neutral to Buy and raises the price target from $18...

baird-maintains-outperform-on-icon-raises-price-target-to-224
Baird Maintains Outperform on Icon, Raises...
09/02/2025 15:22:52

Baird analyst Eric Coldwell maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $222 to $224.

assessing-icon-insights-from-8-financial-analysts
Assessing Icon: Insights From 8 Financial ...
08/21/2025 20:01:08

citigroup-downgrades-icon-to-neutral-lowers-price-target-to-200
Citigroup Downgrades Icon to Neutral, Lowe...
08/21/2025 13:03:04

Citigroup analyst Patrick Donnelly downgrades Icon (NASDAQ:ICLR) from Buy to Neutral and lowers the price target from $225 t...

thermo-fisher-baker-hughes-and-iqvia-holdings-are-among-top-10-large-cap-gainers-last-week-july-21-july-25-are-the-others-in-your-portfolio
Thermo Fisher, Baker Hughes And IQVIA Hold...
07/27/2025 14:16:06

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

mizuho-maintains-outperform-on-icon-raises-price-target-to-225
Mizuho Maintains Outperform on Icon, Raise...
07/25/2025 17:25:53

Mizuho analyst Ann Hynes maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $173 to $225.

ubs-maintains-buy-on-icon-raises-price-target-to-240
UBS Maintains Buy on Icon, Raises Price Ta...
07/25/2025 15:28:29

UBS analyst John Sourbeer maintains Icon (NASDAQ:ICLR) with a Buy and raises the price target from $170 to $240.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION